Developmental and tissue-specific expression of human flavin-containing monooxygenases 1 and 3

By Hines Ronald N  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 2, Iss. 1, 2006-02 ,pp. : 41-49

Informa Healthcare

Access to resources Recommend Favorite

Structured therapy interruption may augment HIV-1-specific immunity in patients with chronic HIV-1 infection

By  

Inpharma, Vol. 1, Iss. 1259, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Tissue-specific Cushing's syndrome uncovers a new target in treating the metabolic syndrome – 11β-hydroxysteroid dehydrogenase type 1

By Stewart Paul M  

Clinical Medicine, Vol. 5, Iss. 2, 2005-03 ,pp. : 142-146

Royal College Of Physicians

Access to resources Recommend Favorite

Darunavir: In the Treatment of HIV-1 Infection

By Fenton Caroline   Perry Caroline M.  

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2791-2801

Adis International

Access to resources Recommend Favorite

Antiretroviral therapies in HIV-1 infection

By Morris-Jones S.   Moyle G.   Easterbrook P.J.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite